Pei Cai

865 total citations
45 papers, 709 citations indexed

About

Pei Cai is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Pei Cai has authored 45 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Oncology. Recurrent topics in Pei Cai's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Medicinal Plants and Neuroprotection (8 papers) and Alzheimer's disease research and treatments (6 papers). Pei Cai is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Medicinal Plants and Neuroprotection (8 papers) and Alzheimer's disease research and treatments (6 papers). Pei Cai collaborates with scholars based in China, United States and Spain. Pei Cai's co-authors include Xiaobing Wang, Xuelian Yang, Ling‐Yi Kong, Jia‐Jia Wu, Qiaohong Liu, Qiaohong Liu, Huali Yang, Siqiang Fang, Fan Li and Ding‐Qiao Xu and has published in prestigious journals such as Nature Methods, Journal of Agricultural and Food Chemistry and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Pei Cai

41 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei Cai China 17 300 231 207 158 140 45 709
Junfang Li China 18 145 0.5× 197 0.9× 290 1.4× 78 0.5× 78 0.6× 53 793
Maria de Jesus Perry Portugal 16 163 0.5× 243 1.1× 212 1.0× 133 0.8× 108 0.8× 34 734
Gopichand Gutti India 13 238 0.8× 183 0.8× 211 1.0× 217 1.4× 80 0.6× 24 593
Daniel Chavarria Portugal 14 210 0.7× 196 0.8× 336 1.6× 66 0.4× 114 0.8× 40 932
Marco Pistolozzi China 18 237 0.8× 103 0.4× 412 2.0× 118 0.7× 156 1.1× 40 896
Yuanying Fang China 16 159 0.5× 234 1.0× 285 1.4× 90 0.6× 46 0.3× 54 663
Vijay K. Nuthakki India 13 208 0.7× 163 0.7× 185 0.9× 116 0.7× 100 0.7× 27 607
Ashish Ranjan Dwivedi India 15 288 1.0× 465 2.0× 216 1.0× 203 1.3× 68 0.5× 45 828
Jihyae Ann South Korea 20 82 0.3× 154 0.7× 521 2.5× 101 0.6× 167 1.2× 68 975

Countries citing papers authored by Pei Cai

Since Specialization
Citations

This map shows the geographic impact of Pei Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Cai more than expected).

Fields of papers citing papers by Pei Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Cai. The network helps show where Pei Cai may publish in the future.

Co-authorship network of co-authors of Pei Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Pei Cai. A scholar is included among the top collaborators of Pei Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei Cai. Pei Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Juan, et al.. (2025). Decoding the pharmacodynamics of Fufang Tongye Shaoshang You: A promising ethnomedicine for diabetic ulcer healing. Journal of Ethnopharmacology. 347. 119727–119727.
2.
Cai, Pei, Zhou Cai, Meiling Chen, et al.. (2025). Distinguishing atypical parotid carcinomas and pleomorphic adenomas based on multiphasic computed tomography radiomics nomogram: a multicenter study. Frontiers in Oncology. 15. 1625487–1625487. 1 indexed citations
4.
Zheng, Yi, et al.. (2025). Proteomic and metabolomic analysis of serum in women infected with COVID-19 during late pregnancy. Frontiers in Immunology. 16. 1589239–1589239.
5.
Cai, Pei, et al.. (2025). Chitosan and sodium alginate-coated liposomes as a novel delivery system for apple peel polyphenols: Preparation, characterization, stability, bioactivity, and in vitro digestion. Innovative Food Science & Emerging Technologies. 104. 104153–104153. 2 indexed citations
6.
Cai, Pei, et al.. (2025). A deep learning sex-specific body composition ageing biomarker using dual-energy X-ray absorptiometry scan. Communications Medicine. 5(1). 171–171. 1 indexed citations
7.
Cai, Pei, et al.. (2025). Association of serum N,N,N-trimethyl-5-aminovaleric acid, trimethylamine N-oxide, and trimethyllysine levels with gestational diabetes mellitus. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2467999–2467999. 1 indexed citations
8.
Zheng, Yi, Mimi Tang, Zheng Deng, & Pei Cai. (2024). Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review. Frontiers in Pharmacology. 15. 1445328–1445328. 1 indexed citations
9.
Huang, Fuqiang, Na Zhao, Pei Cai, et al.. (2024). Active AKT2 stimulation of SREBP1/SCD1-mediated lipid metabolism boosts hepatosteatosis and cancer. Translational research. 268. 51–62. 7 indexed citations
10.
Huang, Fuqiang, Jing Guo, Na Zhao, et al.. (2024). PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1. Journal of Translational Medicine. 22(1). 254–254. 4 indexed citations
12.
Yuan, Lei, Shaofang Xie, Huiru Bai, et al.. (2023). Reconstruction of dynamic mammary mini gland in vitro for normal physiology and oncogenesis. Nature Methods. 20(12). 2021–2033. 20 indexed citations
13.
Yang, Guowei, Xiang Sun, Hao‐Xian Yang, et al.. (2022). 1256P Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial. Annals of Oncology. 33. S1122–S1122. 2 indexed citations
14.
Cai, Pei, et al.. (2018). Lx2-32c inhibits the formation of mammosphere from MDA-MB-231 cells and induces apoptosis involving in down-regulating FoxM1. Biomedicine & Pharmacotherapy. 102. 1176–1181. 2 indexed citations
15.
Yang, Xuelian, Pei Cai, Qiaohong Liu, et al.. (2018). Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 26(12). 3191–3201. 56 indexed citations
16.
Yang, Huali, Pei Cai, Qiaohong Liu, et al.. (2018). Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease. European Journal of Medicinal Chemistry. 163. 307–319. 43 indexed citations
17.
Yang, Huali, Pei Cai, Qiaohong Liu, et al.. (2017). Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid- β aggregation for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 138. 715–728. 50 indexed citations
18.
Li, Fan, Jia‐Jia Wu, Xuelian Yang, et al.. (2017). Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer's disease. Bioorganic & Medicinal Chemistry. 25(14). 3815–3826. 53 indexed citations
19.
Qiu, Bo, Hao‐Xian Yang, Wenjun Xie, et al.. (2016). Combined Modalities of Magnetic Resonance Imaging, Endoscopy, and Computed Tomography in Evaluation of Tumor Response to Definitive Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 96(2). E169–E170. 1 indexed citations
20.
Cai, Pei, Peihua Lu, Frances J. Sharom, & Wei‐Shuo Fang. (2013). A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro. Cancer Letters. 341(2). 214–223. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026